Veracyte Inc
NASDAQ:VCYT
Veracyte Inc
NASDAQ:VCYT
Price:
32.25
USD
-0.46%
Market Closed
Market Cap:
$2.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Veracyte Inc
NASDAQ:VCYT
|
US |
|
Paccar Inc
NASDAQ:PCAR
|
US |
|
Nihon ISK Co Ltd
TSE:7986
|
JP |
|
Demant A/S
CSE:DEMANT
|
DK |
|
Finsbury Food Group PLC
LSE:FIF
|
UK |
|
New Zealand King Salmon Co Ltd
NZX:NZK
|
NZ |
|
Hudson Technologies Inc
NASDAQ:HDSN
|
US |
|
S
|
Saxlund Group AB
STO:SAXG
|
SE |
|
B
|
Benares Hotels Ltd
BSE:509438
|
IN |
|
Midea Real Estate Holding Ltd
HKEX:3990
|
CN |
|
Xamble Group Ltd
ASX:XGL
|
MY |
|
F
|
FuJian YanJing HuiQuan Brewery Co Ltd
SSE:600573
|
CN |
|
Solar A/S
F:ZVR
|
DK |
|
China Nonferrous Mining Corp Ltd
HKEX:1258
|
CN |
|
Andhra Paper Ltd
NSE:ANDHRAPAP
|
IN |
|
Zorlu Enerji Elektrik Uretim AS
IST:ZOREN.E
|
TR |
|
UK Oil & Gas PLC
LSE:UKOG
|
UK |
|
X
|
Ximei Resources Holding Ltd
HKEX:9936
|
CN |
|
Learning Technologies Group PLC
LSE:LTG
|
UK |
|
Mercia Asset Management PLC
LSE:MERC
|
UK |
Multiples-Based Value
The
Multiples-Based Value for
Veracyte Inc (VCYT)
under the Base Case is
hidden
USD.
Compared with the current market price of 32.25 USD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
VCYT Multiples-Based Value
LOCKED
Multiples Across Competitors
VCYT Competitors Multiples
Veracyte Inc Competitors
Veracyte Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Veracyte Inc
NASDAQ:VCYT
|
2.6B USD | 5 | 38.9 | 21.9 | 27.9 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
369.2B USD | 6 | 88.2 | 14.6 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.4B USD | 5.9 | 20.4 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.4B USD | 9.3 | 28.2 | 21.2 | 22.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.5B USD | 5.6 | 17.9 | 13.3 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD | 3.1 | 34 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR | 11.3 | 36.2 | 39.3 | 40.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
